Abstract
Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Current Signal Transduction Therapy
Title:Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines
Volume: 8 Issue: 2
Author(s): Judit Molnar, Imre Ocsovszki, Laszlo Puskas, Tannaz Ghane, Judit Hohmann and István Zupko
Affiliation:
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Abstract: Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Export Options
About this article
Cite this article as:
Molnar Judit, Ocsovszki Imre, Puskas Laszlo, Ghane Tannaz, Hohmann Judit and Zupko István, Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines, Current Signal Transduction Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/15743624113086660006
DOI https://dx.doi.org/10.2174/15743624113086660006 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Estimation of Affinity of HLA-A*0201 Restricted CTL Epitope Based on the SCORE Function
Protein & Peptide Letters Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation
Current Molecular Medicine A Pathogenetic Approach to Autoimmune Skin Disease Therapy: Psoriasis and Biological Drugs, Unresolved Issues, and Future Directions
Current Pharmaceutical Design Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles
Anti-Cancer Agents in Medicinal Chemistry Notch Signaling: A Potential Therapeutic Target in Prostate Cancer
Current Cancer Drug Targets Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Tropical Ginger Extract as Protectant in Radiation Countermeasures
Current Traditional Medicine Role of Glucocorticoids in Breast Cancer
Current Pharmaceutical Design B7-H3 Immune Checkpoint Protein in Human Cancer
Current Medicinal Chemistry CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology Positron Emission Tomography Imaging of Tumor Hypoxia
Current Medical Imaging Electrical Impedance Scanning - A New Diagnostic Tool in Cancer Detection: Current Status and Recent Developments
Current Medical Imaging Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Current Drug Therapy The Medicinal Chemistry Implications of the Anticancer Effects of Aspirin and Other NSAIDs
Mini-Reviews in Medicinal Chemistry Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters Current Patents on Osteoinductive Molecules for Bone Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued)